Ligand Pharmaceuticals Inc (LGND)
Operating Income Growth
394.55%
TTM · Period ending:
LGND Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported394.55%period ending
Latest reported394.55%period ending
LGND TTM Operating Income YoY % (33.97% → 394.55%)
Year-over-year change
High-resolution chart · PNG
LGND operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 26.3186% | |
| 19.8044% | |
| 18.5044% | |
| 30.0219% | |
| 27.3428% | |
| 22.0933% | |
| 19.1092% | |
| -43.9076% | |
| -71.4634% | |
| -103.8012% | |
| -126.7101% | |
| -20.8122% | |
| -13.5734% | |
| 3.9326% | |
| 5.8282% | |
| -34.0136% | |
| -19.9336% | |
| -125.3165% | |
| -136.2319% | |
| -162.5% | |
| -262.6506% | |
| 18.5567% | |
| 33.9713% |